UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.12B |
| 2 |
Apple
AAPL
|
+$1.08B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
Nike
NKE
|
+$1.03B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$821M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioMarin Pharmaceuticals
BMRN
|
+$389M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$383M |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$348M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$263M |
| 5 |
NRG Energy
NRG
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.8% |
| 2 | Financials | 8.25% |
| 3 | Healthcare | 6.4% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Communication Services | 4.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3701
St. Joe Company
JOE
$3.77B
| $2.15M | ﹤0.01% |
39,360
+11,391
| +41% | +$641K |
|
3702
Cimpress
CMPR
$2.29B
| $2.15M | ﹤0.01% |
24,573
+2,982
| +14% | +$260K |
|
|
PLYM
3703
DELISTED
Plymouth Industrial REIT
PLYM
| $2.15M | ﹤0.01% |
100,655
-17,699
| -15% | -$371K |
|
3704
Virtu Financial
VIRT
$4.92B
| $2.15M | ﹤0.01% |
95,826
+27,536
| +40% | +$614K |
|
|
EMTL
3705
DELISTED
State Street DoubleLine Emerging Markets Fixed Income ETF
EMTL
| $2.15M | ﹤0.01% |
50,824
-165
| -0.3% | -$6.93K |
|
3706
Q2 Holdings
QTWO
$3.96B
| $2.15M | ﹤0.01% |
35,575
-27,864
| -44% | -$1.6M |
|
3707
BOK Financial
BOKF
$8.7B
| $2.15M | ﹤0.01% |
23,415
+9,506
| +68% | +$859K |
|
3708
iShares Core 10+ Year USD Bond ETF
ILTB
$591M
| $2.14M | ﹤0.01% |
43,123
+9,465
| +28% | +$469K |
|
3709
Supernus Pharmaceuticals
SUPN
$2.74B
| $2.14M | ﹤0.01% |
80,086
+15,542
| +24% | +$450K |
|
|
DOCU
3710
CALL
DocuSign
DOCU
$11.4B
| $2.14M | ﹤0.01% |
40,000
-120,300
| -75% | -$6.78M |
|
|
CHY
3711
Calamos Convertible and High Income Fund
CHY
$1.07B
| $2.14M | ﹤0.01% |
191,737
+28,880
| +18% | +$324K |
|
3712
Goldman Sachs Equal Weight US Large Cap Equity ETF
GSEW
$2.05B
| $2.13M | ﹤0.01% |
29,987
+536
| +2% | +$38K |
|
3713
Janux Therapeutics
JANX
$1B
| $2.13M | ﹤0.01% |
50,868
+28,664
| +129% | +$1.35M |
|
3714
Federated Hermes
FHI
$4.71B
| $2.13M | ﹤0.01% |
64,649
-127,172
| -66% | -$4.27M |
|
3715
Papa John's
PZZA
$785M
| $2.12M | ﹤0.01% |
45,230
+18,714
| +71% | +$1.02M |
|
3716
OFG Bancorp
OFG
$2.2B
| $2.12M | ﹤0.01% |
56,534
+14,715
| +35% | +$536K |
|
3717
Clearfield
CLFD
$391M
| $2.11M | ﹤0.01% |
54,844
-7,544
| -12% | -$262K |
|
|
DX
3718
Dynex Capital
DX
$3.17B
| $2.11M | ﹤0.01% |
177,077
+30,103
| +20% | +$362K |
|
3719
Aptus Collared Investment Opportunity ETF
ACIO
$2.43B
| $2.11M | ﹤0.01% |
56,153
-2,631
| -4% | -$95.3K |
|
3720
iShares MSCI Emerging Markets Small-Cap ETF
EEMS
$374M
| $2.11M | ﹤0.01% |
34,558
+934
| +3% | +$56.1K |
|
3721
DXC Technology
DXC
$1.74B
| $2.11M | ﹤0.01% |
110,513
+10,595
| +11% | +$199K |
|
3722
Vestis
VSTS
$1.83B
| $2.11M | ﹤0.01% |
172,231
-35,810
| -17% | -$517K |
|
3723
Global X Social Media ETF
SOCL
$93.6M
| $2.1M | ﹤0.01% |
49,831
-831
| -2% | -$34.8K |
|
3724
Crescent Capital BDC
CCAP
$430M
| $2.1M | ﹤0.01% |
111,842
+23,993
| +27% | +$428K |
|
3725
Camtek
CAMT
$7.38B
| $2.1M | ﹤0.01% |
16,758
-626
| -4% | -$59.8K |
|
Similar funds
UBS Group's Q2 2024 Portfolio in Review
As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
UBS Group's Q2 2024 filing shows 1,231 new, 3,688 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
- UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
- UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
- UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
- UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
- UBS Group opened 1,231 new positions and closed 1,043 in Q2 2024.
- UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.
Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.